Yayınlar & Eserler

Yayın Ağı
Makaleler 13
Tümü (13)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (13)
ESCI (1)
Scopus (13)
TRDizin (2)

1. Novel triazole-urea hybrids as promising EGFR inhibitors: Synthesis, molecular modeling and antiproliferative activity studies against breast cancer

TÜRE A., Gülcan M. M., DİNGİŞ BİRGÜL S. İ., Erdoğan O., Erdoğan Ö., ÖZ TUNCAY F., et al.
Journal of Molecular Structure , cilt.1347, 2025 (SCI-Expanded) identifier

2. Synthesis, In Vitro Evaluation, and Molecular Docking Studies of Novel 3,5-Diphenyl-1H-1,2,4-Triazole Derivatives as Potential hEGFR Inhibitors

KOLCUOĞLU Y., BEKİRCAN O., Ustalar N., TÜRE A., Akdemir A., Sanlier S. H.
Archiv der Pharmazie , cilt.358, sa.5, 2025 (SCI-Expanded) identifier identifier

3. Synthesis of novel triazole-urea hybrids and their antiproliferative activity against pancreatic cancer through suppression of eEF2K and induction of apoptosis

TÜRE A., ÖZDEMİR B., Çeçe O., ARMAGAN G., Erdoğan M. A., Erdoğan Ö., et al.
Journal of Molecular Structure , cilt.1311, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

4. Design and synthesis of new heterocyclic compounds containing 5-[(1H-1,2,4-triazol-1-yl)methyl]-3H-1,2,4-triazole-3-thione structure as potent hEGFR inhibitors

KOLCUOĞLU Y., BEKİRCAN O., Fazli H., Sahin E., TÜRE A., AKDEMİR A., et al.
Journal of Biomolecular Structure and Dynamics , cilt.41, sa.22, ss.12753-12767, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

5. Synthesis and molecular modeling of some novel hydroxypyrone derivatives as antidermatophytic agents

Karakaya G., Ozdemir A., Ture A., ÖZÇELİK B., Aytemir M.
JOURNAL OF HETEROCYCLIC CHEMISTRY , cilt.59, sa.10, ss.1801-1812, 2022 (SCI-Expanded) identifier identifier

6. Novel fluoroquinolones containing 2-arylamino-2-oxoethyl fragment: Design, synthesis, evaluation of antibacterial and antituberculosis activities and molecular modeling studies

KULABAŞ N., TÜRE A., Bozdeveci A., Krishna V. S., ALPAY KARAOĞLU Ş., Sriram D., et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY , cilt.59, ss.909-926, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

7. Design, synthesis, and anticancer activity of novel 4-thiazolidinone-phenylaminopyrimidine hybrids

TÜRE A., ERGÜL M., ERGÜL M., ALTUN A., KÜÇÜKGÜZEL İ.
MOLECULAR DIVERSITY , cilt.25, sa.2, ss.1025-1050, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

8. Novel 2,6-disubstituted pyridine hydrazones: Synthesis, anticancer activity, docking studies and effects on caspase-3-mediated apoptosis

Şenkardeş S., Türe A., Ekrek S., Durak A. T., Abbak M., Çevik Ö., et al.
JOURNAL OF MOLECULAR STRUCTURE , cilt.1223, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

9. Molecular modeling and assessment of cytotoxic and apoptotic potentials of imatinib analogues featuring (thio)urea motifs in human leukemia and lymphoma cells

BİNGÖL ÖZAKPINAR Ö., TÜRE A., KÜÇÜKGÜZEL İ.
JOURNAL OF RESEARCH IN PHARMACY , cilt.24, sa.6, ss.801-811, 2020 (ESCI) identifier identifier

10. Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents

TÜRE A., KULABAŞ N., Dingiş S. İ., Birgül K., Bozdeveci A., ALPAY KARAOĞLU Ş., et al.
Bioorganic Chemistry , cilt.88, 2019 (SCI-Expanded) identifier identifier identifier

11. Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives

Karakaya G., TÜRE A., ERCAN A., ÖNCÜL S., Aytemir M. D.
Bioorganic Chemistry , cilt.88, 2019 (SCI-Expanded) identifier identifier identifier

12. Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine-(thio)urea hybrids as potential kinase inhibitors

TÜRE A., Kahraman D. C., Cetin-Atalay R., Helvacioglu S., Charehsaz M., KÜÇÜKGÜZEL İ.
COMPUTATIONAL BIOLOGY AND CHEMISTRY , cilt.78, ss.227-241, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

13. Synthesis and evaluation of novel 1,3,4-thiadiazole-fluoroquinolone hybrids as antibacterial, antituberculosis, and anticancer agents

Demirci A., Karayel K. G., TATAR E., Oktem Okullu S., Unubol N., Tasli P. N., et al.
TURKISH JOURNAL OF CHEMISTRY , cilt.42, sa.3, ss.839-858, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 23

1. Novel Modified Fluoroquinolone Derivatives As Potential Antibacterial And Anti-Tuberculosis Agents: Design, Synthesis And Molecular Modeling Studies

Türe A.
Asian Federation of Medicinal Chemistry (AFMC) 12th International Symposium, İstanbul, Türkiye, 8 - 11 Eylül 2019, ss.108-109, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

2. Novel Imatinib Analogues Featuring (Thio)urea Motifs: Design, Molecular Modeling and Assessment of Cytotoxic and Apoptotic Potential in Human Leukemia and Lymphoma

TÜRE A., BİNGÖL ÖZAKPINAR Ö., KÜÇÜKGÜZEL İ.
6th International BAU Drug Design Congress, 13 - 15 Aralık 2018, (Tam Metin Bildiri)

3. Olası Vegfr2 Inhibitörü Tiyadiazol Halkası Içeren Diaril Üre Ve Diaril Tiyoüre Bileşiklerinin Moleküler Kenetlenme Çalışmaları Işığında Tasarımı Ve Sentezi

Türe A., Sarı S., Acar Ş., Apak A. F. B., Mercimek I. N., Küçükgüzel İ.
2. Ulusal Marmara Eczacılık Kongresi, İstanbul, Türkiye, 14 - 16 Kasım 2018, ss.206, (Özet Bildiri)

4. Docking Studies of Kojylmethyl Dichlorobenzyl Piperazine As A Tyrosinase Inhibitor. 10th International Symposium on Pharmaceutical Sciences

AYTEMİR M., TÜRE A., KARAKAYA G.
10th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2018, (Tam Metin Bildiri)

5. Docking Studies of Kojylmethyl Dichlorobenzyl Piperazıne As A Tyrosinase Inhibitor

Aytemir M., Türe A., Karakaya G.
12th ISOPS, Ankara, Türkiye, 26 - 29 Haziran 2018, ss.393, (Tam Metin Bildiri)

6. Computational Design, Synthesis and Antituberculosis Activity of Novel Modified Fluoroquinolone Derivatives

DEMİRCİ A., KULABAŞ N., KRISHNA V. S., SRIRAM D., KÜÇÜKGÜZEL İ.
5th International Bahçeşehir University (BAU) Drug Design Congress, 19 - 21 Ekim 2017, (Özet Bildiri)

7. A Hybrid Approach for the Design, Synthesis and Anticancer Activity of Phenylaminopyrimidine Core Containing 2-Imino-4-thiazolidinone Derivatives

DEMİRCİ A., ERGÜL M., ERGÜL M., ALTUN A., KÜÇÜKGÜZEL İ.
5th Bahçeşehir University Drug Design Congress, 19 - 21 Ekim 2017, (Özet Bildiri)

8. A Hybrid Approach for the Design, Synthesis and Anticancer Activity of Phenylaminopyrimidine Core Containing 2-Imino-4-thiazolidinone Derivatives

DEMİRCİ A., ERGÜL M., ERGÜL M., ALTUN A., KÜÇÜKGÜZEL İ.
5th Bahçeşehir University Drug Design Congress, 19 Ekim 2017, (Özet Bildiri)

9. DESIGN, SYNTHESIS AND ACTIVITY OF SOME NOVEL PHARMACOPHORIC PHENYLAMINOPYRIMIDINE CORE CONTAINING 5-ARYLIDENE-2-ARYLIMINO-4-THIAZOLIDINONE DERIVATIVES TARGETING NEUROBLASTOMA CANCER CELLS

DEMİRCİ A., ERGÜL M., ERGÜL M., ALTUN A., KÜÇÜKGÜZEL İ.
GPSS2017: 2nd Gazi Pharma Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

10. Design, Synthesis and Antibacterial Activitiy of Novel Modified Fluoroquinolone Derivatives

KULABAŞ N., DEMİRCİ A., BOZDEVECİ A., ALPAY KARAOĞLU Ş., KÜÇÜKGÜZEL İ.
3 rd International Multidisciplinary Symposium on Drug Research and Development - DRD 2017, Erzurum, Türkiye, 5 - 07 Ekim 2017, (Özet Bildiri)

11. Synthesis, Antituberculosis Activity and Molecular Docking Study of Some Novel Fluoroquinolone Derivatives

DEMİRCİ A., KULABAŞ N., Dingiş S. İ., Birgül K., Sriram D., KÜÇÜKGÜZEL İ.
EFMC-ASMC17, 27 - 31 Ağustos 2017, (Özet Bildiri)

12. Synthesis, Anticancer Activity and Docking Studies of New Phenylaminopyrimidine Derivatives

DEMİRCİ A., DURMAZ İ., ATALAY R., KÜÇÜKGÜZEL İ.
10th Joint Meeting on Medicinal Chemistry, 25 - 28 Haziran 2017, (Özet Bildiri)

13. ANTİBAKTERİYEL ETKİ GÖSTERMELERİ OLASI YENİ MOKSİFLOKSAZİN TÜREVLERİNİN SENTEZİ VE MOLEKÜLER MODELLEME ÇALIŞMALARI

KULABAŞ N., DEMİRCİ A., DİNGİŞ S. İ., BİRGÜL K., KÜÇÜKGÜZEL İ.
1. Uusal Marmara Eczacılık Kongresi (UMEK), İstanbul, Türkiye, 3 - 05 Kasım 2016

14. Antibakteriyel Etki Göstermeleri Olası Yeni Moksifloksazin Türevlerinin Sentezi ve Moleküler Modelleme Çalışmaları

DEMİRCİ A., KULABAŞ N., DİNGİŞ S. İ., BİRGÜL K., KÜÇÜKGÜZEL İ.
I.Ulusal Marmara Eczacılık Kongresi (UMEK), Türkiye, 3 - 05 Kasım 2016, (Özet Bildiri)

15. Computational Design,Synthesis and Molecular Properties of Novel Modified Fluoroquinolone Derivatives as Potential Antibacterial and Antituberculosis Agents

DEMİRCİ A., KULABAŞ N., DİNGİŞ S. İ., BİRGÜL K., KÜÇÜKGÜZEL İ.
EFMC-International Symposium on Medicinal Chemistry 2016, 28 Ağustos - 01 Eylül 2016, (Özet Bildiri)

16. Design, Synthesis and Anticancer Activity of Novel of Phenylaminopyrimidine Derivatives

DEMİRCİ A., DURMAZ İ., ATALAY R., KÜÇÜKGÜZEL İ.
European School of Medicinal Chemistry 2016, 26 Haziran - 01 Temmuz 2016, (Özet Bildiri)

17. Design, Synthesis and Anticancer Activity of Novel of Phenylaminopyrimidine Derivatives-Seleceted for oral presentation

DEMİRCİ A., DURMAZ İ., ATALAY R., KÜÇÜKGÜZEL İ.
European School of Medicinal Chemistry 2016, 26 Haziran - 01 Temmuz 2016, (Tam Metin Bildiri)

18. Design Synthesis and Molecular Modeling Studies on Novel Fluoroquinolones as Potential DNA Gyrase Inhibitors

KULABAŞ N., DEMİRCİ A., KÜÇÜKGÜZEL İ.
4th International Meeting on Pharmacy and Pharmaceutical Sciences, 18 - 21 Eylül 2014, (Özet Bildiri)

19. Interfacing Chemical Biology and Drug Discovery bildiri kitapçığındaki Novel Fluoroquinolones Containing Azole Heterocycles Synthesis Antibacterial Activity and Molecular Docking Studies

DEMİRCİ A., KÜÇÜKGÜZEL İ., TATAR E., KARAYEL K., ÖKTEM OKULLU S., ÜNÜBOL N., et al.
50th International Conference on Medicinal Chemistry-RICT 2014, 2 - 04 Temmuz 2014

20. Novel Fluoroquinolones Containing Azole Heterocycles Synthesis Antibacterial Activity and Molecular Docking Studies

DEMİRCİ A., KÜÇÜKGÜZEL İ., TATAR E., KARAYEL K. G., ÖKTEM OKULLU S., ÜNÜBOL N., et al.
50th International Conference on Medicinal Chemistry, RICT, 2 - 04 Temmuz 2014, (Özet Bildiri)

21. Design Synthesis and Molecular Modeling Studies on Novel Fluoroquinolones Containing Azole Heterocycles

KARAYEL K. G., DEMİRCİ A., TATAR E., KÜÇÜKGÜZEL İ.
International Multidisciplinary Symposium on Drug Research and Development New Drug Entities & Cancer Research, Nanotechnology & Scientific and Industrial Perspectives, 28 - 30 Kasım 2013, (Özet Bildiri)

22. Synthesis of Some Novel N substituted 4 trans trans farnesylthiobenzamide Derivatives as Potential Anticancer Agents

DEMİRCİ A., ALP A. S., BÜYÜKBİNGÖL M. E.
13th Belgian Organic Synthesis Symposium (BOSS XIII), 2012, 15 - 20 Temmuz 2012, (Özet Bildiri)

23. Synthesis of Some Novel N susbsituted 3 trans trans Farnesythiobenzamide Derivatives as Potential Anticancer Agents

DEMİRCİ A., ALP A. S., BÜYÜKBİNGÖL M. E.
10th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2012, (Özet Bildiri) identifier identifier identifier
Kitaplar 2

1. Cloud-Based High Throughput Virtual Screening in Novel Drug Discovery

OLĞAÇ A., TÜRE A., OLĞAÇ S., Möller S.
High-Performance Modelling and Simulation for Big Data Applications, Kolodziej Joanna, Gonzalez-Velez Horacio, Editör, Springer, ss.250-278, 2019

2. Cloud-Based High Throughput Virtual Screening in Novel Drug Discovery

Olğaç A., Türe A., Olğaç S., Möller S.
Büyük Veri Uygulamaları için Yüksek Performanslı Modelleme ve Simülasyon, Joanna Kolodziej,Horacia Gonzalez-Velez, Editör, Springer, Zug, ss.250-278, 2019 Sürdürülebilir Kalkınma
Metrikler

Yayın

38

Yayın (WoS)

14

Yayın (Scopus)

14

Atıf (WoS)

126

H-İndeks (WoS)

7

Atıf (Scopus)

129

H-İndeks (Scopus)

6

Atıf (Scholar)

29

H-İndeks (Scholar)

1

Atıf (Diğer Toplam)

5

Proje

3

Fikri Mülkiyet

1
BM Sürdürülebilir Kalkınma Amaçları